A federal grant for HIV research is part of $15.7 million the National Institutes for Health awarded to the Wertheim UF Scripps Institute in Jupiter.
Lamivudine/dolutegravir is effective as first-line therapy for HIV infection, with low rates of treatment failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback